Doron Greenbaum is an accomplished executive with extensive experience in external innovation, business development, and start-up management. He has a Ph.D. in Chemical Biology from the University of California, San Francisco, and a Bachelor's degree in Biology/Biological Sciences, and Chemistry from Williams College. Greenbaum also has over 40 publications to his name in various scientific areas such as gene therapy, biologicals, biochemistry, as well as therapeutic experience in neuroscience, fibrosis, oncology and emerging infectious diseases.

Greenbaum's impressive career has included roles such as Director of Drug Discovery Technologies and External Innovation at Biogen, Professor and Director of Research Operations at the Pennsylvania Drug Discovery Institute, CEO of Phelix Therapeutics LLC, and Assistant Professor at the Perelman School of Medicine at the University of Pennsylvania.

Overall, Greenbaum's expertise in chemical biology and drug discovery, along with his strong business acumen, make him a valuable asset to any organization looking to innovate and grow in the biotech industry.